Hadassah

Hadassah Pioneers New Treatment for Liver Cancer

Saturday, Dec 1 2012

The Hadassah University Medical Center, for the first time in Israel, has pioneered a new treatment for liver cancer, using a direct flow of high-voltage electric current to destroy a malignant tumor.

Typically, a cancerous growth in the liver proves fatal, but this new procedure offers hope to those suffering from liver cancer, such as Louis Saznovsky, Hadassah's first patient to receive the treatment.

Mr. Saznovsky explains that because his cancerous growth was attached to blood vessels, it was difficult to reach and remove. The new procedure--Irreversible Electroporation--"does not generate excessive heat or cold in the body and can therefore be applied close to blood vessels and vital organs without harming them," explains Dr. Mouhammad Faroja, Hadassah senior surgeon, who learned the procedure at London's Hammersmith Hospital.

Requiring just a few minutes under anesthesia, the electroporation was a complete success. Mr. Saznovsky, left with only a few scars where the tumor had been, has already returned to work.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More